| scholarly article | Q13442814 |
| P2093 | author name string | An-Hang Yang | |
| Hui-Wen Yang | |||
| Paulus S Wang | |||
| Oscar K Lee | |||
| Chang-Wei Chen | |||
| Hsin-Lin Tsai | |||
| Jei-Wen Chang | |||
| Ling-Yu Yang | |||
| Teng-Lung Lin | |||
| Yee-Yung Ng | |||
| P2860 | cites work | Renal fibrosis: new insights into the pathogenesis and therapeutics | Q36366487 |
| The podocyte's response to injury: role in proteinuria and glomerulosclerosis | Q36474870 | ||
| Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria | Q36559707 | ||
| Renal fibroblasts and myofibroblasts in chronic kidney disease | Q36621203 | ||
| Podocytes in culture: past, present, and future | Q36801026 | ||
| Immunomodulatory properties of mesenchymal stromal cells | Q36896799 | ||
| Mesenchymal stem cells in acute kidney injury | Q36960106 | ||
| Contribution of stem cells to kidney repair | Q37183989 | ||
| BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression | Q37234857 | ||
| How do mesenchymal stromal cells exert their therapeutic benefit? | Q37352910 | ||
| How do regulatory T cells work? | Q37596517 | ||
| Inflammation and EMT: an alliance towards organ fibrosis and cancer progression | Q37668231 | ||
| Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. | Q37698233 | ||
| An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease | Q37718602 | ||
| Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair. | Q37808802 | ||
| Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes | Q37814791 | ||
| Serum creatinine and renal function | Q39641390 | ||
| Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. | Q39698715 | ||
| The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis | Q39984252 | ||
| Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells | Q40375826 | ||
| A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition | Q40493463 | ||
| Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. | Q40499946 | ||
| Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation | Q40666401 | ||
| Stimulation of hepatocyte growth factor production by ascorbic acid and its stable 2-glucoside | Q40855544 | ||
| Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. | Q42444492 | ||
| Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. | Q42495926 | ||
| Phenotypic characterization of regulatory CD4+CD25+ T cells in rats | Q42799074 | ||
| Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells | Q42914079 | ||
| Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium | Q44872746 | ||
| In vitro hepatic differentiation of human mesenchymal stem cells | Q45161776 | ||
| Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways | Q46370804 | ||
| Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure | Q46376455 | ||
| Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. | Q46532258 | ||
| Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. | Q46613204 | ||
| Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure | Q47302183 | ||
| Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. | Q50597496 | ||
| Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. | Q50685836 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. | Q51105200 | ||
| The effects of different growth factors on human bone marrow stromal cells differentiating into hepatocyte-like cells. | Q51839230 | ||
| Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. | Q53557183 | ||
| Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. | Q53661064 | ||
| Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model. | Q54576023 | ||
| Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. | Q54671130 | ||
| Adult rat and human bone marrow stromal cells differentiate into neurons | Q28142919 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro | Q28579283 | ||
| How regulatory T cells work | Q29614262 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms | Q31147648 | ||
| Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression | Q33991001 | ||
| Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics | Q33991048 | ||
| Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation | Q34442918 | ||
| The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells | Q34704081 | ||
| Structure and function of podocytes: an update | Q34731863 | ||
| TGF-beta signaling in renal disease | Q34869314 | ||
| Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells | Q34913402 | ||
| Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury | Q35070778 | ||
| Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis | Q35669339 | ||
| Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis | Q35746891 | ||
| Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action | Q35794379 | ||
| New insights into epithelial-mesenchymal transition in kidney fibrosis | Q36010095 | ||
| Apoptosis in podocytes induced by TGF-beta and Smad7 | Q36041187 | ||
| The role of tubulointerstitial inflammation | Q36064052 | ||
| Macrophages and progressive tubulointerstitial disease. | Q36192823 | ||
| Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. | Q54700019 | ||
| Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-β | Q57247338 | ||
| Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice | Q57702380 | ||
| IFATS Collection: Fibroblast Growth Factor-2-Induced Hepatocyte Growth Factor Secretion by Adipose-Derived Stromal Cells Inhibits Postinjury Fibrogenesis Through a c-Jun N-Terminal Kinase-Dependent Mechanism | Q58415674 | ||
| Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis | Q61648789 | ||
| Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates | Q68885201 | ||
| Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice | Q73557415 | ||
| Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy | Q73647709 | ||
| Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats | Q73928025 | ||
| Xenotransplant cardiac chimera: immune tolerance of adult stem cells | Q74464164 | ||
| The tubulointerstitium in progressive renal disease | Q77291600 | ||
| Renotropic role and therapeutic potential of HGF in the kidney | Q78391032 | ||
| Characterization of endothelial-like cells derived from human mesenchymal stem cells | Q79576208 | ||
| Experimental intravenous cell therapy of acute and chronic renal failure | Q79889596 | ||
| The changing role of stem cell transplantation in childhood | Q81434749 | ||
| Undifferentiated human mesenchymal stem cells (hMSCs) are highly sensitive to mechanical strain: transcriptionally controlled early osteo-chondrogenic response in vitro | Q81541546 | ||
| Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study | Q84586351 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| mesenchymal stem cell | Q1922379 | ||
| P1104 | number of pages | 15 | |
| P304 | page(s) | 2935-2949 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation | |
| P478 | volume | 16 |
| Q26866578 | Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis |
| Q33873259 | Cell-based therapies in kidney disease |
| Q38156153 | Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives |
| Q36105915 | Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq. |
| Q52861093 | Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor. |
| Q38197694 | Melatonin regulates mesenchymal stem cell differentiation: a review. |
| Q49177880 | Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production |
| Q27322429 | Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition |
| Q35665321 | Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells |
Search more.